N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-4-[(1-tert-butylpiperidin-4-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-6-(2,2-dimethylpropyl)-2,6-diazaspiro[3.3]heptane-2-carboxamide;N-tert-butyl-4-(2,2-dimethylpropyl)piperazine-1-carboxamide;N,2-ditert-butyl-2,6-diazaspiro[3.3]heptane-6-carboxamide;N,4-ditert-butylpiperazine-1-carboxamide

C166H328N32O10 — CID 165026500

IUPACN-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-4-[(1-tert-butylpiperidin-4-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-6-(2,2-dimethylpropyl)-2,6-diazaspiro[3.3]heptane-2-carboxamide;N-tert-butyl-4-(2,2-dimethylpropyl)piperazine-1-carboxamide;N,2-ditert-butyl-2,6-diazaspiro[3.3]heptane-6-carboxamide;N,4-ditert-butylpiperazine-1-carboxamide
SMILESCC(C)(C)CN1CC2(C1)CN(C(=O)NC(C)(C)C)C2.CC(C)(C)CN1CCN(C(=O)NC(C)(C)C)CC1.CC(C)(C)NC(=O)C1CCN(CC2CCN(C(C)(C)C)CC2)C1.CC(C)(C)NC(=O)C1CCN(CC2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)NC(=O)C1CCN(CC2CN(C(C)(C)C)C2)C1.CC(C)(C)NC(=O)C1CCN(CC2CN(C(C)(C)C)C2)CC1.CC(C)(C)NC(=O)N1CC2(C1)CN(C(C)(C)C)C2.CC(C)(C)NC(=O)N1CCN(C(C)(C)C)CC1.CC(C)(C)NC(=O)N1CCN(CC2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)NC(=O)N1CCN(CC2CN(C(C)(C)C)C2)CC1
InChIInChI=1S/C20H39N3O.C19H38N4O.C19H37N3O.C18H35N3O.C17H34N4O.C17H33N3O.C15H29N3O.C14H27N3O.C14H29N3O.C13H27N3O/c1-19(2,3)21-18(24)17-9-11-22(12-10-17)15-16-7-13-23(14-8-16)20(4,5)6;1-18(2,3)20-17(24)22-13-11-21(12-14-22)15-16-7-9-23(10-8-16)19(4,5)6;1-18(2,3)20-17(23)16-9-10-21(14-16)13-15-7-11-22(12-8-15)19(4,5)6;1-17(2,3)19-16(22)15-7-9-20(10-8-15)11-14-12-21(13-14)18(4,5)6;1-16(2,3)18-15(22)20-9-7-19(8-10-20)11-14-12-21(13-14)17(4,5)6;1-16(2,3)18-15(21)14-7-8-19(12-14)9-13-10-20(11-13)17(4,5)6;1-13(2,3)7-17-8-15(9-17)10-18(11-15)12(19)16-14(4,5)6;1-12(2,3)15-11(18)16-7-14(8-16)9-17(10-14)13(4,5)6;1-13(2,3)11-16-7-9-17(10-8-16)12(18)15-14(4,5)6;1-12(2,3)14-11(17)15-7-9-16(10-8-15)13(4,5)6/h16-17H,7-15H2,1-6H3,(H,21,24);16H,7-15H2,1-6H3,(H,20,24);15-16H,7-14H2,1-6H3,(H,20,23);14-15H,7-13H2,1-6H3,(H,19,22);14H,7-13H2,1-6H3,(H,18,22);13-14H,7-12H2,1-6H3,(H,18,21);7-11H2,1-6H3,(H,16,19);7-10H2,1-6H3,(H,15,18);7-11H2,1-6H3,(H,15,18);7-10H2,1-6H3,(H,14,17)
InChIKeyLYVFCXUCCJUDJV-UHFFFAOYSA-N
MW2932.66 g/mol
LogP22.76
Rot. Bonds18

About N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-4-[(1-tert-butylpiperidin-4-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-6-(2,2-dimethylpropyl)-2,6-diazaspiro[3.3]heptane-2-carboxamide;N-tert-butyl-4-(2,2-dimethylpropyl)piperazine-1-carboxamide;N,2-ditert-butyl-2,6-diazaspiro[3.3]heptane-6-carboxamide;N,4-ditert-butylpiperazine-1-carboxamide

N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-4-[(1-tert-butylpiperidin-4-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-6-(2,2-dimethylpropyl)-2,6-diazaspiro[3.3]heptane-2-carboxamide;N-tert-butyl-4-(2,2-dimethylpropyl)piperazine-1-carboxamide;N,2-ditert-butyl-2,6-diazaspiro[3.3]heptane-6-carboxamide;N,4-ditert-butylpiperazine-1-carboxamide (PubChem CID 165026500) has the molecular formula C166H328N32O10 and a molecular weight of 2932.66 g/mol. Its IUPAC name is N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-4-[(1-tert-butylpiperidin-4-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-6-(2,2-dimethylpropyl)-2,6-diazaspiro[3.3]heptane-2-carboxamide;N-tert-butyl-4-(2,2-dimethylpropyl)piperazine-1-carboxamide;N,2-ditert-butyl-2,6-diazaspiro[3.3]heptane-6-carboxamide;N,4-ditert-butylpiperazine-1-carboxamide.

Molecular Properties

Compound NameN-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-4-[(1-tert-butylpiperidin-4-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-6-(2,2-dimethylpropyl)-2,6-diazaspiro[3.3]heptane-2-carboxamide;N-tert-butyl-4-(2,2-dimethylpropyl)piperazine-1-carboxamide;N,2-ditert-butyl-2,6-diazaspiro[3.3]heptane-6-carboxamide;N,4-ditert-butylpiperazine-1-carboxamide
PubChem CID165026500
Molecular FormulaC166H328N32O10
Molecular Weight2932.66 g/mol
Exact Mass2930.61
IUPAC NameN-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-4-[(1-tert-butylpiperidin-4-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-6-(2,2-dimethylpropyl)-2,6-diazaspiro[3.3]heptane-2-carboxamide;N-tert-butyl-4-(2,2-dimethylpropyl)piperazine-1-carboxamide;N,2-ditert-butyl-2,6-diazaspiro[3.3]heptane-6-carboxamide;N,4-ditert-butylpiperazine-1-carboxamide
SMILESCC(C)(C)CN1CC2(C1)CN(C(=O)NC(C)(C)C)C2.CC(C)(C)CN1CCN(C(=O)NC(C)(C)C)CC1.CC(C)(C)NC(=O)C1CCN(CC2CCN(C(C)(C)C)CC2)C1.CC(C)(C)NC(=O)C1CCN(CC2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)NC(=O)C1CCN(CC2CN(C(C)(C)C)C2)C1.CC(C)(C)NC(=O)C1CCN(CC2CN(C(C)(C)C)C2)CC1.CC(C)(C)NC(=O)N1CC2(C1)CN(C(C)(C)C)C2.CC(C)(C)NC(=O)N1CCN(C(C)(C)C)CC1.CC(C)(C)NC(=O)N1CCN(CC2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)NC(=O)N1CCN(CC2CN(C(C)(C)C)C2)CC1
InChIInChI=1S/C20H39N3O.C19H38N4O.C19H37N3O.C18H35N3O.C17H34N4O.C17H33N3O.C15H29N3O.C14H27N3O.C14H29N3O.C13H27N3O/c1-19(2,3)21-18(24)17-9-11-22(12-10-17)15-16-7-13-23(14-8-16)20(4,5)6;1-18(2,3)20-17(24)22-13-11-21(12-14-22)15-16-7-9-23(10-8-16)19(4,5)6;1-18(2,3)20-17(23)16-9-10-21(14-16)13-15-7-11-22(12-8-15)19(4,5)6;1-17(2,3)19-16(22)15-7-9-20(10-8-15)11-14-12-21(13-14)18(4,5)6;1-16(2,3)18-15(22)20-9-7-19(8-10-20)11-14-12-21(13-14)17(4,5)6;1-16(2,3)18-15(21)14-7-8-19(12-14)9-13-10-20(11-13)17(4,5)6;1-13(2,3)7-17-8-15(9-17)10-18(11-15)12(19)16-14(4,5)6;1-12(2,3)15-11(18)16-7-14(8-16)9-17(10-14)13(4,5)6;1-13(2,3)11-16-7-9-17(10-8-16)12(18)15-14(4,5)6;1-12(2,3)14-11(17)15-7-9-16(10-8-15)13(4,5)6/h16-17H,7-15H2,1-6H3,(H,21,24);16H,7-15H2,1-6H3,(H,20,24);15-16H,7-14H2,1-6H3,(H,20,23);14-15H,7-13H2,1-6H3,(H,19,22);14H,7-13H2,1-6H3,(H,18,22);13-14H,7-12H2,1-6H3,(H,18,21);7-11H2,1-6H3,(H,16,19);7-10H2,1-6H3,(H,15,18);7-11H2,1-6H3,(H,15,18);7-10H2,1-6H3,(H,14,17)
InChIKeyLYVFCXUCCJUDJV-UHFFFAOYSA-N
XLogP22.76
TPSA362.28 Ų
H-Bond Donors10
H-Bond Acceptors26
Rotatable Bonds18
Heavy Atoms208
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002932.66
LogP ≤ 522.76
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1026

Analyze N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-4-[(1-tert-butylpiperidin-4-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-6-(2,2-dimethylpropyl)-2,6-diazaspiro[3.3]heptane-2-carboxamide;N-tert-butyl-4-(2,2-dimethylpropyl)piperazine-1-carboxamide;N,2-ditert-butyl-2,6-diazaspiro[3.3]heptane-6-carboxamide;N,4-ditert-butylpiperazine-1-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-4-[(1-tert-butylpiperidin-4-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-6-(2,2-dimethylpropyl)-2,6-diazaspiro[3.3]heptane-2-carboxamide;N-tert-butyl-4-(2,2-dimethylpropyl)piperazine-1-carboxamide;N,2-ditert-butyl-2,6-diazaspiro[3.3]heptane-6-carboxamide;N,4-ditert-butylpiperazine-1-carboxamide?
The IUPAC name of N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-4-[(1-tert-butylpiperidin-4-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-6-(2,2-dimethylpropyl)-2,6-diazaspiro[3.3]heptane-2-carboxamide;N-tert-butyl-4-(2,2-dimethylpropyl)piperazine-1-carboxamide;N,2-ditert-butyl-2,6-diazaspiro[3.3]heptane-6-carboxamide;N,4-ditert-butylpiperazine-1-carboxamide (CID 165026500) is N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-4-[(1-tert-butylpiperidin-4-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-6-(2,2-dimethylpropyl)-2,6-diazaspiro[3.3]heptane-2-carboxamide;N-tert-butyl-4-(2,2-dimethylpropyl)piperazine-1-carboxamide;N,2-ditert-butyl-2,6-diazaspiro[3.3]heptane-6-carboxamide;N,4-ditert-butylpiperazine-1-carboxamide.
What is the SMILES notation for N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-4-[(1-tert-butylpiperidin-4-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-6-(2,2-dimethylpropyl)-2,6-diazaspiro[3.3]heptane-2-carboxamide;N-tert-butyl-4-(2,2-dimethylpropyl)piperazine-1-carboxamide;N,2-ditert-butyl-2,6-diazaspiro[3.3]heptane-6-carboxamide;N,4-ditert-butylpiperazine-1-carboxamide?
The canonical SMILES for N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-4-[(1-tert-butylpiperidin-4-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-6-(2,2-dimethylpropyl)-2,6-diazaspiro[3.3]heptane-2-carboxamide;N-tert-butyl-4-(2,2-dimethylpropyl)piperazine-1-carboxamide;N,2-ditert-butyl-2,6-diazaspiro[3.3]heptane-6-carboxamide;N,4-ditert-butylpiperazine-1-carboxamide is CC(C)(C)CN1CC2(C1)CN(C(=O)NC(C)(C)C)C2.CC(C)(C)CN1CCN(C(=O)NC(C)(C)C)CC1.CC(C)(C)NC(=O)C1CCN(CC2CCN(C(C)(C)C)CC2)C1.CC(C)(C)NC(=O)C1CCN(CC2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)NC(=O)C1CCN(CC2CN(C(C)(C)C)C2)C1.CC(C)(C)NC(=O)C1CCN(CC2CN(C(C)(C)C)C2)CC1.CC(C)(C)NC(=O)N1CC2(C1)CN(C(C)(C)C)C2.CC(C)(C)NC(=O)N1CCN(C(C)(C)C)CC1.CC(C)(C)NC(=O)N1CCN(CC2CCN(C(C)(C)C)CC2)CC1.CC(C)(C)NC(=O)N1CCN(CC2CN(C(C)(C)C)C2)CC1.
What is the InChIKey of N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-4-[(1-tert-butylpiperidin-4-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-6-(2,2-dimethylpropyl)-2,6-diazaspiro[3.3]heptane-2-carboxamide;N-tert-butyl-4-(2,2-dimethylpropyl)piperazine-1-carboxamide;N,2-ditert-butyl-2,6-diazaspiro[3.3]heptane-6-carboxamide;N,4-ditert-butylpiperazine-1-carboxamide?
The InChIKey is LYVFCXUCCJUDJV-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H39N3O.C19H38N4O.C19H37N3O.C18H35N3O.C17H34N4O.C17H33N3O.C15H29N3O.C14H27N3O.C14H29N3O.C13H27N3O/c1-19(2,3)21-18(24)17-9-11-22(12-10-17)15-16-7-13-23(14-8-16)20(4,5)6;1-18(2,3)20-17(24)22-13-11-21(12-14-22)15-16-7-9-23(10-8-16)19(4,5)6;1-18(2,3)20-17(23)16-9-10-21(14-16)13-15-7-11-22(12-8-15)19(4,5)6;1-17(2,3)19-16(22)15-7-9-20(10-8-15)11-14-12-21(13-14)18(4,5)6;1-16(2,3)18-15(22)20-9-7-19(8-10-20)11-14-12-21(13-14)17(4,5)6;1-16(2,3)18-15(21)14-7-8-19(12-14)9-13-10-20(11-13)17(4,5)6;1-13(2,3)7-17-8-15(9-17)10-18(11-15)12(19)16-14(4,5)6;1-12(2,3)15-11(18)16-7-14(8-16)9-17(10-14)13(4,5)6;1-13(2,3)11-16-7-9-17(10-8-16)12(18)15-14(4,5)6;1-12(2,3)14-11(17)15-7-9-16(10-8-15)13(4,5)6/h16-17H,7-15H2,1-6H3,(H,21,24);16H,7-15H2,1-6H3,(H,20,24);15-16H,7-14H2,1-6H3,(H,20,23);14-15H,7-13H2,1-6H3,(H,19,22);14H,7-13H2,1-6H3,(H,18,22);13-14H,7-12H2,1-6H3,(H,18,21);7-11H2,1-6H3,(H,16,19);7-10H2,1-6H3,(H,15,18);7-11H2,1-6H3,(H,15,18);7-10H2,1-6H3,(H,14,17).
What are the key properties of N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-4-[(1-tert-butylpiperidin-4-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-6-(2,2-dimethylpropyl)-2,6-diazaspiro[3.3]heptane-2-carboxamide;N-tert-butyl-4-(2,2-dimethylpropyl)piperazine-1-carboxamide;N,2-ditert-butyl-2,6-diazaspiro[3.3]heptane-6-carboxamide;N,4-ditert-butylpiperazine-1-carboxamide?
N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-4-[(1-tert-butylpiperidin-4-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-6-(2,2-dimethylpropyl)-2,6-diazaspiro[3.3]heptane-2-carboxamide;N-tert-butyl-4-(2,2-dimethylpropyl)piperazine-1-carboxamide;N,2-ditert-butyl-2,6-diazaspiro[3.3]heptane-6-carboxamide;N,4-ditert-butylpiperazine-1-carboxamide has a molecular weight of 2932.66 g/mol, XLogP of 22.76, 18 rotatable bonds, 10 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for N-tert-butyl-4-[(1-tert-butylazetidin-3-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylazetidin-3-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-4-[(1-tert-butylpiperidin-4-yl)methyl]piperazine-1-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]piperidine-4-carboxamide;N-tert-butyl-1-[(1-tert-butylpiperidin-4-yl)methyl]pyrrolidine-3-carboxamide;N-tert-butyl-6-(2,2-dimethylpropyl)-2,6-diazaspiro[3.3]heptane-2-carboxamide;N-tert-butyl-4-(2,2-dimethylpropyl)piperazine-1-carboxamide;N,2-ditert-butyl-2,6-diazaspiro[3.3]heptane-6-carboxamide;N,4-ditert-butylpiperazine-1-carboxamide is sourced from PubChem (CID 165026500), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).